New drug for rare eye disease begins first human tests
Knowledge-focused
Recruiting now
This early-phase trial tests the safety of an oral drug called DC6001 in 76 healthy adults. Researchers will give single or multiple doses to see how the body handles the drug and if it causes side effects. This study does not involve people with Stargardt disease and is not desi…
Phase: PHASE1 • Sponsor: Heronova Pharmaceuticals • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:06 UTC